Literature DB >> 7683263

Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

J Y Lau1, G L Bird, N V Naoumov, R Williams.   

Abstract

To determine the relationship between hepatitis B virus (HBV) replication and HLA antigen display at a cellular level, the hepatic expression of HLA antigens and HBV genome (HBV-DNA)/gene products (HBsAg/HBcAg) was studied in 24 patients with chronic HBV infection using simultaneously immunohistochemistry and nonisotopic in situ hybridization. The effect of interferon-alpha and interferon-gamma on hepatocyte HLA antigen expression was also evaluated using primary hepatocyte culture in eight patients with chronic HBV infection. HLA class I antigens were detected on hepatocyte membrane in 23 patients (95.8%). Hepatocytes positive for HBcAg and HBV-DNA (cytoplasmic +/- nuclear) were either negative or only faintly positive for HLA class I antigens, while hepatocytes positive for HBsAg showed similar levels of HLA class I antigen expression compared with those hepatocytes with no HBsAg expression. In contrast, hepatocytes adjacent to inflammatory infiltrates, whether positive for HBV-DNA or HBV antigens or not, were always strongly positive for HLA class I antigens. Furthermore, active liver histology (N = 12) was associated with a higher overall level of hepatic HLA class I antigen expression as compared with inactive histology (N = 12, P = 0.003). Both interferon-alpha and interferon-gamma treatment in vitro enhanced hepatocyte HLA class I antigen expression. These data indicate that expression of HLA class I antigens is not enhanced on the membrane of hepatocytes with HBV replication, and this may be one factor that permits the development of viral persistence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683263     DOI: 10.1007/bf01295916

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

Review 2.  Expression of class I transplantation antigens.

Authors:  H W Harris; T J Gill
Journal:  Transplantation       Date:  1986-08       Impact factor: 4.939

3.  Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases.

Authors:  Y Kato; H Nakagawa; K Kobayashi; N Hattori; K Hatano
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

4.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin.

Authors:  G H Wong; I Clark-Lewis; A W Harris; J W Schrader
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

6.  Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue.

Authors:  A R Jilbert; C J Burrell; E J Gowans; P J Hertzog; A W Linnane; B P Marmion
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

7.  Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.

Authors:  R I Lechler; M A Norcross; R N Germain
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes.

Authors:  M L Tiku; S Liu; C W Weaver; M Teodorescu; J L Skosey
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.

Authors:  G Senaldi; A Lobo-Yeo; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

10.  Expression of interferon-gamma receptor in normal and pathological human liver tissue.

Authors:  R Volpes; J J van den Oord; R De Vos; E Depla; M De Ley; V J Desmet
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

View more
  7 in total

1.  Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.

Authors:  T I Michalak; P D Hodgson; N D Churchill
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.

Authors:  S I Khakoo; R Ling; I Scott; A I Dodi; T J Harrison; G M Dusheiko; J A Madrigal
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

3.  Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.

Authors:  M J Hussain; J Y Lau; R Williams; D Vergani
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

4.  The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.

Authors:  Bryan M Burt; George Plitas; Zeguo Zhao; Zubin M Bamboat; Hoang M Nguyen; Bo Dupont; Ronald P DeMatteo
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

5.  Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B.

Authors:  T I Michalak; J Y Lau; B M McFarlane; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

6.  Blood Group Antigen Expression in Isolated Human Liver Cells in Preparation for Implementing Clinical ABO-Incompatible Hepatocyte Transplantation.

Authors:  Kazuaki Tokodai; Makiko Kumagai-Braesch; Ahmad Karadagi; Helene Johansson; Nils Ågren; Carl Jorns; Bo-Göran Ericzon; Ewa Ellis
Journal:  J Clin Exp Hepatol       Date:  2019-07-11

7.  Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha.

Authors:  Christian B Willberg; Scott M Ward; Reginald F Clayton; Nikolai V Naoumov; Christopher McCormick; Sandra Proto; Mark Harris; Arvind H Patel; Paul Klenerman
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.